Advertisement

Anesthesiology pp 755-764 | Cite as

Organ Harvesting and the Role of Anesthesiologist

  • Michael R. Schwartz
  • Erin W. Pukenas
Chapter

Abstract

The ability to procure and allocate organs is dependent on patient comorbidities, logistical factors and ethical considerations. The anesthesia team plays a critical role in supporting organ donation which may include donation after brain death (DBD) or donation after cardiac death (DCD) procurements. Careful monitoring and management of the donor patient’s circulatory, respiratory, hematologic and endocrine parameters specific to organ donation type can improve transplant outcomes for the recipient.

Keywords

Organ procurement organization Donation after brain death Donation after cardiac death Ethics Organ allocation 

References

  1. 1.
  2. 2.
    Wijdicks EFM, Varelas PN, Gronseth GS, et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:1911–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Bernat JL, D’lessandro AM, Port FK, et al. Report of a national conference on donation after cardiac death. Am J Transplant. 2006;6:281–91.CrossRefPubMedGoogle Scholar
  4. 4.
    Campbell GM, Sutherland FR. Non-heart-beating organ donors as a source of kidneys for transplantation: a chart review. CMAJ. 1999;160:1573–6.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Klein AS, Messersmith EE, Ratner LE, et al. Organ donation and utilization in the United States, 1999–2008. Am J Transplant. 2010;10(Pt 2):973.CrossRefPubMedGoogle Scholar
  6. 6.
    Kowalski AE, Light JA, Ritchie WO, Sasaki TM, Callender CO, Gage F. A new approach for increasing the organ supply. Clin Transpl. 1996;10:653–7.Google Scholar
  7. 7.
    Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304:2620–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation. 1993;56:1418–21.CrossRefPubMedGoogle Scholar
  9. 9.
    Martin J, Lutter G, Ihling C, et al. Myocardial viability twenty-four hours after orthotopic heart transplantation from non-heart-beating donors. J Thorac Cardiovasc Surg. 2003;125:1217–28.CrossRefPubMedGoogle Scholar
  10. 10.
    President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Defining death: a report on the medical, legal, and ethical issues in the determination of death. Washington, DC: Government Printing Office; 1981.Google Scholar
  11. 11.
    Barclay WR. Guidelines for the determination of death. JAMA. 1981;246(19):2194.  https://doi.org/10.1001/jama.1981.03320190052031.CrossRefPubMedGoogle Scholar
  12. 12.
    Wijdicks EFM. Brain death worldwide: accepted fact but no global consensus in diagnostic criteria. Neurology. 2002;58:20–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant. 2005;5(4 Pt 1):684–93.CrossRefPubMedGoogle Scholar
  14. 14.
    Belzberg H, Shoemaker WC, Wo CC, et al. Hemodynamic and oxygen transport patterns after head trauma and brain death: implications for management of the organ donor. J Trauma. 2007;63:1032–42.CrossRefPubMedGoogle Scholar
  15. 15.
    Szabo G. Physiologic changes after brain death. J Heart Lung Transplant. 2004;23(9 Suppl):S223–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Plurad DS, Bricker S, Neville A, Bongard F, Putnam B. Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors. Am J Surg. 2012;204:856–60.CrossRefPubMedGoogle Scholar
  17. 17.
    Audibert G, Charpentier C, Seguin-Devaux C, et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation. 2006;82:1031–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002;2:701–11.CrossRefPubMedGoogle Scholar
  19. 19.
    Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620–2.CrossRefPubMedGoogle Scholar
  20. 20.
    Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth. 2008;100:504–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 1995;59:58–62.CrossRefPubMedGoogle Scholar
  22. 22.
    Shemie SD, Ross H, Pagliarello J, et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ. 2006;174:S13–32.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Schnuelle P, Lorenz D, Mueller A, Trede M, Van Der Woude FJ. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int. 1999;56:738–46.CrossRefPubMedGoogle Scholar
  24. 24.
    Abdelnour T, Rieke S. Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant. J Heart Lung Transplant. 2009;28(5):480.CrossRefPubMedGoogle Scholar
  25. 25.
    Gelb AW, Robertson KM. Anaesthetic management of the brain dead for organ donation. Can J Anaesth. 1990;37:806–12.CrossRefPubMedGoogle Scholar
  26. 26.
    McKeown DW, Bonser RS, Kellum JA. Management of the heartbeating brain-dead organ donor. Br J Anaesth. 2012;108(Suppl 1):i96–107.CrossRefPubMedGoogle Scholar
  27. 27.
    Dictus C, Vienenkoetter B, Esmaeilzadeh M, Unterberg A, Ahmadi R. Critical care management of potential organ donors: our current standard. Clin Transpl. 2009;23(Suppl 21):2–9.CrossRefGoogle Scholar
  28. 28.
    Wood KE, Becker BN, McCartney JG, D’Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med. 2004;351:2730–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacological donor management results in more transplanted organs. Transplantation. 2003;75:482–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Lucangelo U, Del Sorbo L, Boffini M, Ranieri VM. Protective ventilation for lung transplantation. Curr Opin Anesthesiol. 2012;25(2):170–4.CrossRefGoogle Scholar
  31. 31.
    Cortjens B, Royakkers AA, Determann RM, et al. Lung-protective mechanical ventilation does not protect against acute kidney injury in patients without lung injury at onset of mechanical ventilation. J Crit Care. 2011;27(3):261–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology. 1994;80:606–10.CrossRefPubMedGoogle Scholar
  33. 33.
    Yoo KY, Jeong CW, Kim SJ, et al. Sevoflurane concentrations required to block autonomic hyperreflexia during transurethral litholapaxy in patients with complete spinal cord injury. Anesthesiology. 2008;108(5):858–63.CrossRefPubMedGoogle Scholar
  34. 34.
    De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg. 2005;100(6):1584–93.CrossRefPubMedGoogle Scholar
  35. 35.
    Arbour R. Clinical management of the organ donor. AACN Clin Issues. 2005;16(4):551–80.CrossRefPubMedGoogle Scholar
  36. 36.
    Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation. 2003;75(12):1928–33.CrossRefPubMedGoogle Scholar
  37. 37.
    Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation. 2004;78(7):978–86.CrossRefPubMedGoogle Scholar
  38. 38.
    Kaminska D, Tyran B, Mazanowska O, et al. Cytokine gene expression in kidney allograft biopsies after donor brain death and ischemia-reperfusion injury using in situ reverse-transcription polymerase chain reaction analysis. Transplantation. 2007;84(9):1118–24.CrossRefPubMedGoogle Scholar
  39. 39.
    Sánchez-Fructuoso AI, Prats D, Marques M, et al. Does donor brain death influence acute vascular rejection in the kidney transplant? Transplantation. 2004;78(1):142–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Antognini JF, Berg K. Cardiovascular responses to noxious stimuli during isoflurane anesthesia are minimally affected by anesthetic action in the brain. Anesth Analg. 1995;81(4):843–8.PubMedGoogle Scholar
  41. 41.
    Du Pont-Thibodeau G, Harrington K, Lacroix J. Anemia and red blood cell transfusion in critically ill cardiac patients. Ann Intensive Care. 2014;4:16.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Van Bakel AB. The cardiac transplant donor: identification, assessment, and management. Am J Med Sci. 1997;314(3):152–63.Google Scholar
  43. 43.
    Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D’Alessandro A, Dec GW, Edwards NM, Higgins RS, Jeevanandum V, Kauffman M, Kirklin JK, Large SR, Marelli D, Peterson TS, Ring WS, Robbins RC, Russell SD, Taylor DO, Van Bakel A, Wallwork J, Young JB. Consensus conference report maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation. 2002;106:836–41.CrossRefPubMedGoogle Scholar
  44. 44.
    Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan LS, Demetriades D. Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma. 2009;66:55–61; discussion 61–2CrossRefPubMedGoogle Scholar
  45. 45.
    de Oliveira Manoel AL, Neto AC, Veigas PV, Rizoli S. Traumatic brain injury associated coagulopathy. Neurocrit Care. 2014;22(1):34–44.  https://doi.org/10.1007/s12028-014-0026-4.CrossRefGoogle Scholar
  46. 46.
    Hefty TR, Cotterell LW, Fraser SC, Goodnight SH, Hatch TR. Disseminated intravascular coagulation in cadaveric organ donors: incidence and effect on renal transplantation. Transplantation. 1993;55:442–3.CrossRefPubMedGoogle Scholar
  47. 47.
    Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356:2301–11.  https://doi.org/10.1056/NEJMra067742.CrossRefPubMedGoogle Scholar
  48. 48.
    Brown JE, Olujohungbe A, Chang J, Ryder WD, Morganstern GR, Chopra R, Scarffe JH. All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia. Br J Haematol. 2000;110:1010–2.  https://doi.org/10.1046/j.1365-2141.2000.02270-8.x.CrossRefPubMedGoogle Scholar
  49. 49.
    de la Serna J, Montesinos P, Vellenga E, Rayon C, Parody R, Leon A, Esteve J, Bergua JM, Milone G, Deben G, Rivas C, Gonzalez M, Tormo M, az-Mediavilla J, Gonzalez JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008;111:3395–402.  https://doi.org/10.1182/blood-2007-07-100669.CrossRefPubMedGoogle Scholar
  50. 50.
    Walsh M, Thomas SG, Howard JC, Evans E, Guyer K, Medvecz A, et al. Blood component therapy in trauma guided with the utilization of the perfusionist and thromboelastography. J Extra Corpor Technol. 2011;43:162–7.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 1987;43:852–4.CrossRefPubMedGoogle Scholar
  52. 52.
    Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior and posterior pituitary function in brain-stem-dead donors. Transplantation. 1989;47:828–34.CrossRefPubMedGoogle Scholar
  53. 53.
    Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant. 2002;2:761–8.CrossRefPubMedGoogle Scholar
  54. 54.
    Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006;82(11):1396–401.CrossRefPubMedGoogle Scholar
  55. 55.
    Dhar R, Cotton C, Coleman J, et al. Comparison of high- and low-dose corticosteroid regimens for organ donor management. J Crit Care. 2013;28:111.e1–7.CrossRefGoogle Scholar
  56. 56.
    Masson F, Thicoipe M, Gin H, De Mascarel A, Angibeau RM, Favarel-Garrigues JF, et al. The endocrine pancreas in brain-dead donors. Transplantation. 1993;56(2):363–7.CrossRefPubMedGoogle Scholar
  57. 57.
    Nunnally ME, O’Connor MF. Glycemic control for organs: a new approach to a controversial topic. J Cardiothorac Vasc Anesth. 2005;19:689–90.CrossRefPubMedGoogle Scholar
  58. 58.
    University of Pittsburgh. MOnIToR Study. https://crisma.upmc.com/MonitorStudy/index.asp. Accessed Jan 2015.
  59. 59.
    Blasi-Ibanez A, Hirose R, Feiner J, Freise C, Stock P, Roberts JP, Niemann CU. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology. 2009;110:333–41.PubMedGoogle Scholar
  60. 60.
    Sally MB, Ewing T, Crutchfield M, et al. Determining optimal threshold for glucose control in organ donors after neurologic determination of death: a United Network for Organ Sharing Region 5 Donor Management Goals Workgroup prospective analysis. J Trauma Acute Care Surg. 2014;76:62–8; discussion 68–9CrossRefPubMedGoogle Scholar
  61. 61.
    Malinoski DJ, Patel MS, Daly MC, Oley-Graybill C, Salim A, UNOS Region 5 DMG Workgroup. The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med. 2012;40:2773–80.CrossRefPubMedGoogle Scholar
  62. 62.
    Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999;5:421–8.CrossRefPubMedGoogle Scholar
  63. 63.
    Rech TH, Moraes RB, Crispim D, Czepielewski MA, Leitao CB. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation. 2013;95:966–74.CrossRefPubMedGoogle Scholar
  64. 64.
    Rosendale JD, Kauffman HM, McBride MA, et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation. 2003;75:1336–41.CrossRefPubMedGoogle Scholar
  65. 65.
    Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134(1):172–8.  https://doi.org/10.1378/chest.07-2331.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology. 2005;103:419–28.CrossRefPubMedGoogle Scholar
  67. 67.
    Bakkar J, Nijsten M, Jansen T. Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care. 2013;3:12.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyCooper Medical School of Rowan University/Cooper University Health CareCamdenUSA

Personalised recommendations